Speaker illustration

Doctor Benjamin Van Tassell

Virginia Commonwealth University, Richmond (United States of America)

Recombinant Interleukin-1 receptor antagonist for the treatment of ST-segment elevation acute myocardial infarction prevents future heart failure events: a pooled analysis of the VCUART program

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Pharmacotherapy

Session: Acute Coronary Syndromes ePosters

Thumbnail

Predictive role of C-reactive protein levels in patients with ST-segment elevation acute myocardial infarction for heart failure related events

Event: ESC CONGRESS 2019

Topic: Prevention

Session: Is inflammation really important in heart failure?

Thumbnail

Effects of Interleukin-1 blockade with anakinra in patients with ST-segment elevation acute myocardial infarction on recurrent ischemic events: results from the VCUART3 study

Event: ESC CONGRESS 2019

Topic: Pharmacotherapy

Session: Inflammation

Thumbnail

Interleukin-1 blockade in recently decompensated systolic heart failure: the recently decompensated heart failure anakinra response trial (REDHART)

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Acute heart failure (management)

Session: Moderated Poster session 5 - Tips and tricks to prevent readmissions

Thumbnail

ESC 365 is supported by

logo Novo Nordisk